Millennium Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Millennium Management’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,861	Closed	-$25K	–	6657
2023 Q3	$25K	Sell	2,861 -549	-16%	-$5.14K	﹤0.01%	5603
2023 Q2	$40.1K	Sell	3,410 -4,460	-57%	-$64.1K	﹤0.01%	5514
2023 Q1	$135K	Buy	7,870 +268	+4%	+$5.81K	﹤0.01%	5319
2022 Q4	$200K	Buy	+7,602	New	+$361K	﹤0.01%	5339
2021 Q4	–	Sell	-2,096	Closed	-$404K	–	7502
2021 Q3	$404K	Sell	2,096 -2,435	-54%	-$517K	﹤0.01%	5541
2021 Q2	$1.09M	Sell	4,531 -5,056	-53%	-$1.39M	﹤0.01%	4585
2021 Q1	$3.25M	Buy	9,587 +5,498	+134%	+$2.24M	﹤0.01%	3052
2020 Q4	$1.46M	Buy	+4,089	New	+$1.57M	﹤0.01%	3468
2020 Q3	–	Sell	-796	Closed	-$115K	–	4902
2020 Q2	$115K	Sell	796 -1,435	-64%	-$181K	﹤0.01%	3960
2020 Q1	$214K	Sell	2,231 -1	-0%	-$119	﹤0.01%	3361
2019 Q4	$299K	Buy	+2,232	New	+$286K	﹤0.01%	3669

Other funds holding TFFP

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Millennium Management's TFFP Position: Q4 2023 in Review

Millennium Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2023, closing a stake of 2,861 shares — an estimated $25K sold.

Millennium Management first reported a position in TFFP in Q4 2019 and held it in 11 quarters. The position peaked at $3.25M in Q1 2021. 23 funds tracked by Wall St. Rank hold TFFP as of Q4 2023.

Millennium Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Millennium Management sold 2,861 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $25K.
Millennium Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
Millennium Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $3.25M in Q1 2021.
23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.